HomePDSB • NASDAQ
add
PDS Biotechnology Corp
Previous close
$1.56
Day range
$1.58 - $1.76
Year range
$0.85 - $4.42
Market cap
77.25M USD
Avg Volume
608.26K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.11M | -9.82% |
Net income | -8.49M | 19.94% |
Net profit margin | — | — |
Earnings per share | -0.21 | 30.00% |
EBITDA | -9.09M | 9.84% |
Effective tax rate | 12.11% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 39.98M | -40.00% |
Total assets | 47.03M | -31.85% |
Total liabilities | 24.67M | -22.49% |
Total equity | 22.36M | — |
Shares outstanding | 45.71M | — |
Price to book | 3.18 | — |
Return on assets | -49.28% | — |
Return on capital | -55.42% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -8.49M | 19.94% |
Cash from operations | -9.03M | 9.12% |
Cash from investing | — | — |
Cash from financing | 7.32M | -63.42% |
Net change in cash | -1.71M | -116.98% |
Free cash flow | -2.68M | 58.04% |
About
Founded
2005
Website
Employees
24
